These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8051627)

  • 1. [Phospholipid dynamics and function in cell membrane of blood cells. With reference to mode of action of certain amphiphilic drugs].
    Fujii T
    Yakugaku Zasshi; 1994 Jun; 114(6):374-87. PubMed ID: 8051627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of cepharanthine on collagen-induced activation in rabbit platelets.
    Kometani M; Kanaho Y; Sato T; Fujii T
    Eur J Pharmacol; 1985 Apr; 111(1):97-105. PubMed ID: 3926512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of membrane lipids and proteins in discocyte-echinocyte and -stomatocyte transformation of erythrocytes.
    Fujii T
    Acta Biol Med Ger; 1981; 40(4-5):361-7. PubMed ID: 7315084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biscoclaurine alkaloids inhibit receptor-mediated phospholipase A2 activation probably through uncoupling of a GTP-binding protein from the enzyme in rat peritoneal mast cells.
    Akiba S; Kato E; Sato T; Fujii T
    Biochem Pharmacol; 1992 Jul; 44(1):45-50. PubMed ID: 1632837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxidative stress on membrane phospholipid and protein organization in human erythrocytes.
    Arduini A; Stern A; Storto S; Belfiglio M; Mancinelli G; Scurti R; Federici G
    Arch Biochem Biophys; 1989 Aug; 273(1):112-20. PubMed ID: 2757386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2.
    Kinkaid AR; Othman R; Voysey J; Wilton DC
    Biochim Biophys Acta; 1998 Feb; 1390(2):173-85. PubMed ID: 9507109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets.
    Hashizume T; Yamaguchi H; Sato T; Fujii T
    Biochem Pharmacol; 1991 Feb; 41(3):419-23. PubMed ID: 1899790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane skeleton-bilayer interaction is not the major determinant of membrane phospholipid asymmetry in human erythrocytes.
    Gudi SR; Kumar A; Bhakuni V; Gokhale SM; Gupta CM
    Biochim Biophys Acta; 1990 Mar; 1023(1):63-72. PubMed ID: 2317498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.
    Fourcade O; Simon MF; Viodé C; Rugani N; Leballe F; Ragab A; Fournié B; Sarda L; Chap H
    Cell; 1995 Mar; 80(6):919-27. PubMed ID: 7697722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis.
    Fourcade O; Le Balle F; Fauvel J; Simon MF; Chap H
    Adv Enzyme Regul; 1998; 38():99-107. PubMed ID: 9762349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of 4'-O-substituted 1-benzylisoquinolines with respect to their actions on the cell membrane of blood platelets and erythrocytes.
    Fujii T; Sato T; Tamura A; Kometani M; Nakao K; Fujitani K; Kodama K; Akasu M
    Eur J Pharmacol; 1988 Feb; 146(2-3):285-90. PubMed ID: 3131148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by cepharanthine is accomplished during the early, membrane-related activation process.
    Watanabe S
    Acta Med Okayama; 1984 Apr; 38(2):101-15. PubMed ID: 6731025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of TMEM16A/ANO1 and TMEM16F/ANO6 ion currents and phospholipid scrambling by Ca
    Schreiber R; Ousingsawat J; Wanitchakool P; Sirianant L; Benedetto R; Reiss K; Kunzelmann K
    J Physiol; 2018 Jan; 596(2):217-229. PubMed ID: 29134661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular attack.
    Zager RA; Sacks BM; Burkhart KM; Williams AC
    Kidney Int; 1999 Jul; 56(1):104-17. PubMed ID: 10411684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of enzymatic phospholipid cleavage on the permeability of the erythrocyte membrane: III. Discrimination between the causal role of split products and of lecithin removal.
    Deuticke B; Grunze M; Forst B; Luetkemeier P
    J Membr Biol; 1981 Mar; 59(1):45-55. PubMed ID: 7241575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane phospholipid asymmetry in DMPC-induced human red cell vesicles.
    de Jong K; Ott P
    FEBS Lett; 1993 Nov; 334(2):183-8. PubMed ID: 8224245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High specificity of human secretory class II phospholipase A2 for phosphatidic acid.
    Snitko Y; Yoon ET; Cho W
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):737-41. PubMed ID: 9032461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial cytotoxins, amphotericin B and local anesthetics enhance transbilayer mobility of phospholipids in erythrocyte membranes. Consequences for phospholipid asymmetry.
    Schneider E; Haest CW; Plasa G; Deuticke B
    Biochim Biophys Acta; 1986 Mar; 855(3):325-36. PubMed ID: 3081027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.
    Dise CA; Burch JW; Goodman DB
    J Biol Chem; 1982 May; 257(9):4701-4. PubMed ID: 6802839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.